Join us at the IPAC-RS 2026 Nasal Innovation Forum, taking place in Jersey City, New Jersey, from 16–17 September 2026.
This 2 day forum will bring together industry leaders, scientists and regulators to explore key topics shaping the future of nasal drug product development, including device selection, manufacturing best practices, regulatory pathways, successful case studies and the progression of products from discovery into the clinic.
We are pleased to be supporting the event as Silver Sponsors. As an Associate Member of IPAC-RS, Copley is actively engaged in the organisation’s technical initiatives, contributing to discussions that support the advancement of robust, reliable and scientifically grounded approaches to OINDP testing.
Our CEO, Jamie Clayton, will be attending the forum on behalf of Copley and will be available to discuss our comprehensive range of equipment, software and services for inhaled and nasal product testing. As co-chair of the Pharmacopoeia & Regulatory and Nasal Casts sub-teams within the Nasal Working Group, and an active member of a number of IPAC-RS sub-teams, including the APSD Core Team, Jamie will also be pleased to share his expertise and insight across these specialist areas of inhaled and nasal drug delivery.
Whether you have a specific testing challenge or would like to learn more about Copley’s solutions for nasal and inhaled product development and quality control, contact us in advance at [email protected] to arrange a meeting.
